Dengue Vaccine: Considerations before Rollout in Colombia
about
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia: implications for vaccine introductionDeterminants of felt demand for dengue vaccines in the North Caribbean region of ColombiaDiterpenes as lead molecules against neglected tropical diseases.Bayesian dynamic modeling of time series of dengue disease case counts.Evolutionary history and spatio-temporal dynamics of dengue virus serotypes in an endemic region of ColombiaTwo-level resolution of relative risk of dengue disease in a hyperendemic city of Colombia
P2860
Dengue Vaccine: Considerations before Rollout in Colombia
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dengue Vaccine: Considerations before Rollout in Colombia
@ast
Dengue Vaccine: Considerations before Rollout in Colombia
@en
Dengue Vaccine: Considerations before Rollout in Colombia
@nl
type
label
Dengue Vaccine: Considerations before Rollout in Colombia
@ast
Dengue Vaccine: Considerations before Rollout in Colombia
@en
Dengue Vaccine: Considerations before Rollout in Colombia
@nl
prefLabel
Dengue Vaccine: Considerations before Rollout in Colombia
@ast
Dengue Vaccine: Considerations before Rollout in Colombia
@en
Dengue Vaccine: Considerations before Rollout in Colombia
@nl
P2860
P3181
P1476
Dengue Vaccine: Considerations before Rollout in Colombia
@en
P2093
Cinthy Lorena Jimenez Silva
Raquel Elvira Ocazionez Jimenez
P2860
P304
P3181
P356
10.1371/JOURNAL.PNTD.0004653
P407
P577
2016-06-09T00:00:00Z